Onconephrology fellowship training
Promoting education related to onco-nephrology is a principal part of our mission at ASON. Our goal by having this dedicated page to onconephrology fellowship is to provide the trainee interested in onconephrology a general information about the field , and updated and reliable resources to help them applying for the fellowship.
Why choosing onconephrology as a career?
Onconephrology is a rapidly evolving subspecialty that covers all aspect of kidney involvement in cancer patients. A career in onconephrology has ample advantages with primary drivers for most physician entering this filed are the high complexity and acuity, the cross-disciplinary collaboration in caring for a vulnerable patient population, and the fertile ground for research
How can I receive clinical training in onconephrology?
Either within the 2-year nephrology fellowship or completing an additional year of onconephrology clinical or research fellowship
What are the advantages and limitations of each track?
-Onconephrology fellowship track, allows for more relevant clinical experience and adequate time to participate in scholar activity and receive clinical research. However, it is remains a non accredited fellowship.
-Within the 2 year nephrology training track, allows for earlier clinical career in the filed upon graduation.
However, it is limited to certain fellowship programs with attached cancer center and has limited research opportunities.
How long is the fellowship?
One academic year, July through June.
Which academic programs offer Onconephrology fellowship?
Listed in the table below are the 5 academic centers in North America that offer onconephrology fellowship. For more information about each program and the deadline for submitting the application, please visit each program website.
Useful articles about the path to Onconephrology training:
-Latcha S, Kala J, Kitchlu A, Leung N. An extra year of Onco-Nephrology fellowship training is required for the subspecialty: PRO. Journal of Onco-Nephrology. 2021;5(1):31-34. doi:10.1177/2399369320965578